Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218049 · ClinicalTrials.gov registry record · Phase 1
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00218049: Clinical Trial Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00218049 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218049, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
Interventions
- DRUG GBR 12909
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
Why NCT00218049 stopped before completion
NCT00218049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which GBR 12909 is the first listed.
NCT00218049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218049 about?
NCT00218049 is a clinical study titled "Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals". Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
What is the current status of trial NCT00218049?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2004-12. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00218049?
The interventions under investigation include: GBR 12909 (DRUG).
Who is sponsoring clinical trial NCT00218049?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218049's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia